https://www.selleckchem.com/products/am580.html
Since autologous split-thickness skin grafts (STSGs) are scarce and lab skin growth requires a significant amount of time, there are limited available treatment approaches for patients with full thickness 90% total burn surface area (TBSA). Additionally, to achieve the primary goal of skin coverage and resuscitation, there must exist a balance between fluid loss and metabolic derangement. Allografts and xenografts have traditionally been used early in the process to achieve these goals. Currently, novel approaches to treatment conside
Gefällt mir
Kommentar
Teilen
